What is Cupron?
Cupron is at the forefront of developing and applying copper-based antimicrobial technologies. The company embeds specific copper compounds into polymers, creating durable materials that offer inherent antimicrobial benefits for healthcare, consumer goods, industrial applications, and military use. Unlike surface treatments, Cupron's embedded technology ensures long-lasting efficacy, as the copper compounds do not wash or wear off, providing a persistent defense against microbial contamination.
How much funding has Cupron raised?
Cupron has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Cupron?
With its large-scale late-stage funding context, Cupron is well-positioned for significant expansion and market penetration. The company's focus on durable, embedded copper technology suggests a strategy aimed at integrating its solutions into a wide array of products where antimicrobial properties are critical. Future growth is likely to involve scaling manufacturing capabilities, forging strategic partnerships, and further research and development to explore new applications for its innovative copper-based materials, solidifying its leadership in the antimicrobial technology space.
See full Cupron company page
